Table 1.
Baseline characteristics of type 2 diabetic patients who failed to maintain optimal glycemic control with a combination of maximum dosage of metformin and sulfonylurea (MFM-SUF group), and the normal glucose tolerance (NGT) group
| Variable | MFM-SUF group (n=25) | NGT group (n=28) | p-value |
|---|---|---|---|
| Age (years) | 56.8±9.8 (range 37–78) | 53.8±6.7 (range 46–68) | 0.29 |
| Gender, women | 14 (56) | 26 (92.9) | 0.02 |
| Duration of diabetes (years) | 12 (7.5, 14) | N/A | |
| BMI (kg/m2) | 25.8±4.7 (range 18.1–37.2) | 26.4±3.6 (range 19.7–36.6) | 0.77 |
| HbA1c (%) | 9.5±1.4 | N/A | |
| HbA1c (mmol/mol) | 80.0±7.3 | N/A | |
| FPG (mmol/L) | 11.0±2.2 | N/A | |
| Metformin dose (g/day) | 2.2±0.8 | N/A |
Notes: Data are shown as mean±SD, n (%), or median (IQR).
Abbreviations: BMI, body mass index; FPG, fasting plasma glucose; NA, not applicable.